Chesnara Plc: Fourth acquisition in two years
12 November 2026
Kura Oncology, Inc. (NASDAQ: KURA) stands at the forefront of biotechnology innovation with its focus on developing targeted therapies for cancer treatment. Headquartered in San Diego,..
Autolus Therapeutics plc (NASDAQ: AUTL) is making waves in the biotechnology sector with an ambitious focus on developing cutting-edge T cell therapies to combat cancer and..
For investors seeking opportunities in the biotech sector, Humacyte, Inc. (NASDAQ: HUMA) presents an intriguing proposition. This Durham, North Carolina-based company is pioneering advancements in bioengineered..
For investors seeking promising opportunities in the biotechnology sector, Precigen, Inc. (NASDAQ: PGEN) stands out as a compelling option. The company, with a focus on innovative..
For investors eyeing opportunities in the healthcare sector, AxoGen, Inc. (NASDAQ: AXGN) presents an intriguing proposition with its focus on pioneering technologies for peripheral nerve regeneration..
Keros Therapeutics, Inc. (NASDAQ: KROS), a promising player in the biotechnology sector, has been making waves with its innovative approach to addressing complex medical conditions. With..
Oruka Therapeutics, Inc. (ORKA) is carving a niche for itself within the biotechnology sector, focusing on innovative treatments for psoriasis and other inflammatory conditions. As a..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a cutting-edge player in the biotechnology sector, is currently captivating investors with its promising pipeline and notable upside potential. With a..
ATAI Life Sciences N.V. (NASDAQ: ATAI) is capturing the attention of investors with its pioneering approach to mental health treatments and a staggering potential upside of..
Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector under the Medical Care Facilities industry, is drawing attention with a remarkable 31% revenue..
Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, specializes in drug manufacturing with a focus on specialty and generic solutions. The company’s..
Verastem, Inc. (NASDAQ: VSTM) presents an intriguing opportunity for investors with its significant potential upside of over 221%, according to analyst ratings. As a biopharmaceutical company..
Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at a crossroads with its intriguing blend of clinical diagnostic and therapeutic development solutions. With a market capitalization of $595.17..
Verve Therapeutics, Inc. (NASDAQ: VERV) is capturing investor attention in the biotechnology sector with its promising gene editing medicines aimed at combating cardiovascular diseases. Operating from..
Definitive Healthcare Corp. (NASDAQ: DH) stands at a crucial juncture as it navigates the dynamic landscape of the healthcare information services industry. With a market capitalization..
Prothena Corporation plc (NASDAQ: PRTA), a promising player in the biotechnology sector, is capturing investor attention with its remarkable 269.65% potential upside. Headquartered in Dublin, Ireland,..
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing the attention of investors with its compelling growth potential in the biotechnology sector. With a market capitalization of..
For investors with a penchant for healthcare opportunities, Abivax SA (ABVX) presents an intriguing prospect in the biotechnology sector. Based in France, Abivax is a clinical-stage..
LifeMD, Inc. (NASDAQ: LFMD) is emerging as a significant player in the rapidly evolving healthcare sector, specifically within the health information services industry. With a market..
